ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

Phenylacetate

HCID 4409936
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

標準SMILES
O=C([O-])Cc1ccccc1
InChIKey
WLJVXDMOQOGPHL-UHFFFAOYSA-M
分子式
C8H7O2-
平均分子量
135.14 g/mol
単同位体質量
135.04460446

概要

Phenylacetate is a monocarboxylic acid anion that is the conjugate base of phenylacetic acid. It has a role as a Saccharomyces cerevisiae metabolite, a plant metabolite, an Escherichia coli metabolite and a human metabolite. It is functionally related to an acetate. It is a conjugate base of a phenylacetic acid.

名称と識別子

優先名称
Phenylacetate
IUPAC
2-phenylacetate

名称と別名

phenylacetate2-phenylethanoateCHEBI:18401RefChem:9290432-phenylacetateBenzeneacetatephenylacetate anionphenylacetate(1-)phenylacetic acid anionBDBM36183WLJVXDMOQOGPHL-UHFFFAOYSA-Mc0211
名称をさらに表示
AKOS024258138NS00010314AB01275449-01Q27103051

データベース識別子

PubChem CID
4409936
ChEBI
CHEBI:18401
Nikkaji
J1.455.714H

物性

構造計算による物性

XLogP
2.1
極性表面積
40.1 Ų
水素結合供与体数
0
水素結合受容体数
2
回転可能結合数
1
重原子数
10
形式電荷
-1
複雑度
109

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

毒性情報

TreatmentKidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.
Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity Summary · 1 件

Uremic toxins such as phenylacetic acid are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869)

Signs and Symptoms · 1 件

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Carcinogen Classification

化学と産業

薬理情報

Metabolism/MetabolitesUremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.
MeSH Pharmacological ClassificationAntimetabolites that are useful in cancer chemotherapy.

用途と製造

UsesNaturally produced by the body (endogenous).

関連反応

10 件
反応記録を作成
HRID 103876 の反応式
HRID 103876反応物として
HRID 1234312 の反応式
HRID 1234312生成物として
HRID 1294313 の反応式
HRID 1294313反応物として
HRID 1761703 の反応式
HRID 1761703反応物として
HRID 1885800 の反応式
HRID 1885800反応物として
HRID 2289120 の反応式
HRID 2289120反応物として
HRID 2289129 の反応式
HRID 2289129反応物として
HRID 2289135 の反応式
HRID 2289135反応物として
前へ1 / 2 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
No indication of carcinogenicity to humans (not listed by IARC).